MSB 1.02% 99.0¢ mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-129

  1. 6,905 Posts.
    lightbulb Created with Sketch. 1280
    The hope is a partnership. Like what we thought was Novartis. But real!

    It's a different disease and this time there is P3 data to look at whilst embarking on a new one and the FDA seems to be shining a torch on the path (somewhat).

    MSB's 'hand' in negotiating the deal for this one is now heavily weighted towards their benefit.

    The upside (maybe) is the world knows SI has a massive set of testicles so don't even bother if the money isn't right!! Or his unique conditions (whatever the hell they are - I have guessed previously).

    Whispers in the wind will be at an all time high now I reckon. By the looks of the SP movements in advance of the announcements recently, the whispers started a few days ago.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.